Cognition and Memory Enhancement Drugs: Technologies and Global Markets

Jul 2018| PHM184A| BCC Publishing

Report Highlights

The global cognition and memory-enhancing drugs market should reach over $4.2 billion by 2022 from $2.8 billion in 2017 at a compound annual growth rate (CAGR) of 8.7% for the period 2017-2022.

Report Includes

  • 34 data tables and 14 additional tables
  • An overview of the global market for cognition and memory enhancement drugs
  • Analyses of global market trends, with data from 2016 to 2017, and projections of compound annual growth rates (CAGRs) through 2022
  • An overview of the ethics and side effects of cognition and memory enhancement drugs
  • Market analyses by application, product, and region
  • Assessment of patent litigation claims
  • Insight into the competitive landscape, including mergers and acquisitions and new product launches
  • Profiles of key companies in the market, including Pfizer, Novartis, Shire Pharmaceuticals, Allergan Plc, Barr Pharmaceuticals, and Cephalon

Report Scope

This research report presents an in-depth analysis of the global cognition and memory-enhancing drugs market by application, product categories, and regional markets. The report includes key cognition drugs that are incorporated in several therapeutic treatment methods. It discusses the role of supply chain members from manufacturers to researchers. The report has an in-depth analysis of key companies operating in the global cognition and memory-enhancing drugs market. In-depth patent analysis in the report will focus on providing extensive technological trends across years and regions such as the U.S., Europe, and China.

The cognition and memory-enhancing drugs market is segmented mainly into eight components: Aricept, Exelon, Reminyl, Namenda, Adderall, Ritalin, Dexedrin, and other cognition drugs. This market is further segmented on the basis of applications, which helps in understanding the potency of these memory enhancers in several therapeutic treatments. The market study is detailed for products based on applications as well as its further implication on the research and development area. These two segmentations are also discussed in detail for the given period. The market is segmented by region into the North America, Europe, Asia-Pacific, and ROW. Companies profiled in this report include Pfizer, Novartis, Shire Pharmaceuticals, Allergan plc, Barr Pharmaceuticals, and Cephalon.

Analyst Credentials

Sangeeta Rai is a senior researcher who has analyzed and forecasted healthcare and advanced chemicals markets since 2011. She holds a Bachelor of Science in biotechnology and a Master of Business Administration in marketing. Prior to joining BCC Research, she has held senior research roles at Global Data and Infinity Research. Sangeeta Rai is a pseudonym of the author.

Table of Contents & Pricing

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at
Title/Chapter Name Pages Price Member Price
Full Report: Cognition and Memory Enhancement Drugs: Technologies and Global Markets 155 $4,950 Free
Chapter- 1: Introduction5Free DownloadFree
Chapter- 2: Summary and Highlights3$250Free
Chapter- 3: Market and Technology Background46$1,662Free
Chapter- 4: Global Cognition and Memory-enhancing Drugs Market Breakdown by Product Type 14$506Free
Chapter- 5: Global Cognition and Memory-enhancing Drugs Market Breakdown by Application29$1,048Free
Chapter- 6: Global Cognition and Memory-enhancing Drugs Market Breakdown by Region19$686Free
Chapter- 7: Patent Review3$108Free
Chapter- 8: Analysis of Market Opportunities3$108Free
Chapter- 9: Company Profiles15$542Free
Chapter- 10: Appendix: Patents, Drugs and Cognitive Enhancers18$650Free

When do I get the report?
Most reports are fulfilled immediately. In some cases, it could take up to 24 hours.

In what format does this report get delivered to me?
We will send you an email with login credentials to access the report. You will also be able to download the pdf.

What are the free reports included in my purchase?
They consist of a collection of current reports from various partner publishers scanning multiple industries.

What is the difference between BCC Research and BCC Publishing?
BCC Research curates thousands of reports from different sources and provides access to this content to our clients. BCC Publishing is the publication arm of BCC Research (one of several publishers in our portal).

What reports do I get 'discounts' on with my purchase?
All reports. BCC Publishing reports will be available for a 50% discount. All other partner publishers are also available at deeply discounted rates.

Where are you located?
Wellesley Massachusetts, just outside of Boston, Massachusetts, USA.

How long has BCC Research been around?
We are approaching our 50 year anniversary in 2021!

What if I want you to invoice me for payment via Purchase Order?
Simply choose Pay by Purchase Order when you are checking out. We will connect with you via email to set up your order.

What if I have a question about your reports?
Call us, email us, or chat with us! We encourage your questions and feedback. We have a research concierge team available at all times, and included in every purchase, to help our customers find the research they need-when they need it.

Can I share this report with my team?
Absolutely yes, with the purchase of additional user licenses.

Can I use your research in my presentation?
Absolutely yes, so long as the publisher is properly cited.

Why BCC Research?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries

Need a custom data table, graph or complete report? Tell us more.

Contact Us
Share This Report